Madrigal Pharmaceuticals, Inc.

NASDAQ (USD): Madrigal Pharmaceuticals, Inc. (MDGL)

Last Price

236.54

Today's Change

-11.99 (4.82%)

Day's Change

235.10 - 249.98

Trading Volume

466,166

Overview

Market Cap

4 Billion

Shares Outstanding

19 Million

Avg Volume

447,872

Avg Price (50 Days)

225.10

Avg Price (200 Days)

204.81

PE Ratio

-12.29

EPS

-19.25

Earnings Announcement

07-May-2024

Previous Close

248.53

Open

249.36

Day's Range

235.1 - 249.98

Year Range

119.76 - 322.67

Trading Volume

466,166

Price Change Highlight

1 Day Change

-4.82%

5 Day Change

1.58%

1 Month Change

2.77%

3 Month Change

20.96%

6 Month Change

31.91%

Ytd Change

4.27%

1 Year Change

-12.92%

3 Year Change

92.22%

5 Year Change

73.54%

10 Year Change

-2.34%

Max Change

-25.65%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment